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Alex Gamma. Jules Angst 
Concurrent psychiatric comorbidity and multimorbidity in a 
community study: gender differences and quality of life 
Abstract This study analysis of a community cohort 
at the age of 35 focused on the effects of gender and mul- 
timorbidity on quality of life and subjective distress. 
Consistent with an earlier analysis, quality of life 
decreased with increasing numbers of concurrent psy- 
chiatric diagnoses. Women generally reported lower 
quality of life and higher distress than men. Relative to 
men, wen-being in women was subject to more diagnos- 
tic (alcohol abuse/dependence, depression, generalized 
anxiety disorder, bulimia) and social influences (partner, 
promotion). The same factors predicted women's psy- 
chological and physical well-being, indicating a more 
holistic experience inwomen. Men's physical well-being 
did not correlate with any of the diagnostic or social vari- 
ables measured. 
Key words Quality of life 9 distress, prevalence, gen- 
der. comorbidity, multimorbidity 
It was a great pleasure to write this paper in honour of my friend Per 
Bech, in gratitude for his longlasting friendship and his untiring efforts 
as President and past-President of the European Association of Psychi- 
atrists and in recognition of his outstanding contribution to research on 
clinical methodology and quality of life. 
Introduction 
Comorbidity or co-occurrence ofpsychiatric diagnoses 
has become a important issue in classification: comor- 
bidity is frequent and is associated with greater treatment 
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needs, severity and chronicity. Comorbidity denotes pri- 
marily the association of two disorders, but many 
patients receive multiple diagnoses (multimorbidity). 
This problem has been dealt with mainly in the field of 
somatic disorders (Gijsen et al. 2001, Xuan et al. 1999). In 
an earlier analysis we presented data on psychiatric mul- 
timorbidity as an indicator of clinical severity on the 
basis of longitudinal cumulative associations assessed 
by repeated interviews (Angst et al., submitted). That 
study showed the association of the number of diagnoses 
with overall severity, work/social impairment, suicide 
attempt, reatment and prescribed medication rates, and 
with distress and quality of life. Associations within diag- 
nostic spectra (for instance between major depression 
and dysthymia) were more common than between spec- 
tra. 
This paper presents additional data on the impact of 
concurrent multimorbidity (1, 2 and 3+ diagnoses) on 
distress and quality of life (QoL) in subjects aged 35 years 
from the community and gives special consideration to
gender differences. 
Methods 
The Zurich study is a longitudinal epidemiological inves- 
tigation carried out in a community sample from the can- 
ton of Zurich, Switzerland. In 1978, 4457 young adults 
(19-20 years old) were screened using the Symptom 
Checklist 90-Revised (SCL-90R) of Derogatis (1977). For 
the Zurich study, 591 subjects were selected from this 
larger sample, with 396 having an SCL-R score above, and 
195 below the 85th percentile. This weighting scheme was 
ttsed to enrich the sample with potential risk cases. Five 
interview waves have been conducted so far using the 
semi-structured SPIKE interview administered by 
trained clinical psychologists and psychiatrists oassess 
psychiatric and somatic syndromes, ubstance abuse, 
social factors, and quality of life. Symptoms, frequency 
and duration, degree of distress, treatment history, social 
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and work impairment, personal and family history were 
evaluated for each syndrome. The present analysis is 
restricted to the participants of the fifth wave conducted 
in 1993 (215 females and 192 males, aged 34 and 35 
respectively). 
Psychiatric diagnoses were based on the following cri- 
teria: DSM-III: panic disorder, generalized anxiety dis- 
order; DSM-III-R: major depression, dysthymia nd 
bulimia; DSM-IV: bipolar disorder, substance abuse/ 
dependence; ICD-10: neurasthenia. 
The number of psychiatric diagnoses occurring over 
the previous twelve months was calculated for each sub- 
ject, considering the following 14 diagnoses: unipolar 
major depressive disorder (N = 40), unipolar dysthymia 
(9), bipolar disorder I/II (15), generalized anxiety disor- 
der (37), panic disorder (6), agoraphobia (6), social pho- 
bia (6), simple phobia (25), alcohol abuse/dependence 
(40), drug abuse/dependence (9), benzodiazepine 
dependence (5), obsessive-compulsive disorder (5), 
bulimia (4), and neurasthenia (15). Drug abuse/depend- 
ence includes abuse/dependence of opiates, hallucino- 
gens, cocaine, amphetamines and cannabis. 
Quality of life was evaluated in ten domains: work, 
finances, family of origin, friends, physical well-being, 
psychological well-being, spouse/partner, own family, 
childhood, and total distress. A five-point scale (5 = 
excellent, 4 = good, 3 = satisfactory, 2 = poor, 1 = very 
poor) was used to rate quality of life satisfaction or well- 
being in these domains (Bech and Angst 1996). As a fur- 
ther measure, for each of the 14 diagnoses total distress 
was computed as the sum of the individual distress cores 
(0-100). 
Statistical analyses were carried out with SAS for Win- 
dows Version 8.01. Effects of gender and the number of 
individual diagnoses on the quality of life were assessed 
non-parametrically with the Kruskal-Wallis Test. Back- 
ward multiple linear regression analyses (SAS: PROC 
REG) were used to compute diagnostic and social pre- 
dictors of quality of life by gender. All regressions con- 
trolled for risk status (stratified sampling of high-risk 
cases). 
Tab. 1 Frequency and prevalence rates as a function of the number of psychiatric 
diagnoses 
N of diagnoses 0 1 2 3+ 
N (total = 407) 271 83 36 17 
Women (%)* 51.3 56.6 47.2 70.6 
Prevalence (%) 75.4 16.9 5.0 2.7 
Women (%) 76.5 17.9 3.1 2.5 
Men (%) 74.2 15.4 6.9 2.9 
*p=0.35 
Tab.2 Mean scores for different domains of quality of life as a function of gender 
Quality of Life related to: Men Women pa* 
N mean N mean 
Physical well-being 155 3.45 197 3.25 .03 
Psychological well-being 154 3.56 197 3.26 .003 
Family of origin {parents, siblings) 156 3.47 195 3.31 .09 
Own family 87 3.86 130 3.71 .06 
Childhood/adolescence 153 3.32 195 3.02 .005 
Relationship with spouse/partner 129 3.68 169 3.31 .002 
Relationships in general 156 3.61 195 3.62 .99 
Work 156 3.54 196 3.34 .02 
Financial situation 156 3.37 197 3.34 .87 
Total distress 137 74.23 177 112.54 .001 
* Kruskal-Wallis Test, bold figures are statistically significant 
Results 
:J Frequency and prevalence rates 
As expected, frequency and prevalence decreased with an 
increasing number of individual diagnoses: 242 subjects 
of the sample received no psychiatric diagnosis, 83 one 
diagnosis, 36 two diagnoses and 17 three or more diag- 
noses (Table 1). Overall there was no gender difference in
comorbidity, but females predominated in the group 
with three or more diagnoses. At the age of 35, the 
weighted total one-year prevalence of morbidity was 
24.6%, with 5% of the sample receiving two diagnoses 
and 2.7 % three or more. In contrast to the raw figures the 
weighted rates demonstrate an equal distribution of co- 
and multimorbidity between males and females. 
:~ Quality of life and gender 
Gender-related differences in quality of life ratings are 
shown in Table 2. Women rated their quality of life con- 
sistently lower than men in most domains examined. 
These differences were statistically significant for physi- 
cal and psychological well-being, relationship with 
spouse/partner, work, childhood and total distress; in 
addition there was a trend (p < 0.1) towards alower qual- 
ity of life in relationships with family members (both 
family of origin and own family). 
Considering only the subset of subjects without a psy- 
chiatric diagnosis (139 females, 132 males) there was a 
trend towards lower psychological well-being in women 
(F: mean 3.45; M: mean 3.65; p = 0.07), but there was no 
significant gender difference in mean physical well-being 
scores (F 3.44; M 3.51; p = 0.38). Women without any 
psychiatric diagnoses rated their QoL in childhood and 
adolescence much lower than men (F 3.13; M 3.42; p = 
0.02). 
Tab. 3 Physical and psychological well-being as a function of gender and the 
number of psychiatric diagnoses 
N of diagnoses 0 1 2 3+ 
well-being sex mean SD mean SD mean SD mean SD p* 
physical F 3.44 0.74 3.05 0.93 2.87 1.06 2.45 1.13 0.001 
M 3.52 0.77 3.23 0.86 3.33 0.99 3.00 1.0 0.39 
F vs M p** 0.38 0.36 0.20 0.37 - 
psychological F 3.45 0.89 3.07 0.91 3.00 0.93 2.09 1.04 0.001 
M 3.65 0.75 3.42 0.70 2.92 1.08 4.00 0.00 0.01 
FvsM p** 0.07 0.13 0.72 0.02 - 
* Kruskal-Wallis Test for well-being across different numbers of diagnoses, bold 
figures are statistically significant; 
** Kruskal-Wallis Test for well-being across gender, bold figures are statistically 
significant; 5D standard deviation 
Quality of life, multimorbidity and social factors 
Both physical and psychological well-being decreased 
with an increasing number of concurrent diagnoses 
(Table 3). In order to analyze the contribution of specific 
diagnoses and social factors, separate backward multiple 
linear regression analyses were carried out by gender. 
Independent predictors were entered into the model as 
follows: a) social variables: living alone, having a spouse/ 
partner, number of children, level of training, crucial 
changes at work, workload, income, regular financial 
obligations, conflicts at work, promotion, difficulties in 
relationship with spouse/partner, improvement in rela- 
tionship with spouse/partner and birth of a child; b) the 
psychiatric diagnoses for unipolar major depressive dis- 
order, bipolar disorder I/II, generalized anxiety disorder, 
simple phobia, alcohol abuse/dependence, bulimia and 
neurasthenia; (the remaining diagnoses were excluded 
due to insufficient numbers of subjects), and c) risk sta- 
tus as a consequence ofthe sample stratification. 
In women significant predictors of poorer psycholog- 
ical well-being were alcohol dependence (standardized 
beta = -0.28; p < 0.001), unipolar depression (beta = 
-0.22; p = 0.003), bulimia (beta = -0.21; p = 0.003), diffi- 
culties in relationships with spouse/partner (beta = -0.15; 
p = 0.04) whereas promotion exercised a positive effect 
(beta = 0.20; p = 0.01). Women's physical well-being was 
also significantly predicted by bulimia (beta = -0.24; 
p < 0.001), alcohol dependence (beta = -0.21; p = 0.005) 
and difficulties in relationships with spouse/partner 
(beta = -0.15; p = 0.04) but also by generalized anxiety 
disorder (beta = -0.16; p = 0.02); promotion again was a 
positive factor (beta = 0.15; p = 0.03). 
In men the significant predictors of psychological 
well-being were income (beta = 0.21; p = 0.01), simple 
phobia (beta = -0.19; p = 0.02) and sampling stratification 
(beta = -0.23; p = 0.007). Men's physical well-being was 
not predicted by any of the variables examined. 
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Discussion 
The large epidemiological surveys (Kessler et al. 1994, 
Bijl et al. 1998) found no gender differences in the over- 
all lifetime prevalence rates of psychiatric disorders 
(mood disorders, anxiety disorders and substance 
abuse/dependence) but reported higher female preva- 
lence rates for comorbid and multimorbid cases. Our 
one-year prevalence rates for 1, 2 and 3+ diagnoses 
(16.9 %, 5.0% and 2.7%) are similar to those reported by 
Bijl (1998) for the Netherlands (15.3 %, 4.4 %, 3.8 %). Our 
analysis of the raw data showed a significant female pre- 
ponderance among subjects with three or more diag- 
noses, a difference which disappeared after weighting for 
the stratified sampling. The relatively small group sizes 
makes this result inconclusive. In contrast, the National 
comorbidity survey (Kessler et al. 1994), the Nemesis 
study (Bijl et al. 1998) and our earlier longitudinal analy- 
sis (Angst et al. 2001) all showed consistently higher ates 
of comorbidity and multimorbidity for females than 
males. 
We found important gender differences in the sub- 
jects' rating of their quality of life: women rated their QoL 
in most domains ignificantly lower and their distress (as 
a consequence of psychiatric disorders) significantly 
higher than men; this result is in agreement with Bech et 
al.'s (1996) finding that men scored higher on the WHO 
(Ten) Well-Being Index. Childhood/adolescence 
received especially low QoL ratings, particularly from 
women. 
The main findings refer to gender differences in psy- 
chological and physical well-being, which would not have 
been expected on the basis of a factor analysis of Ruggeri 
et al. (2001) where the two loaded on the same factor. 
Confirming the results of our earlier analysis (Angst et al. 
2001), we found that psychological well-being tended to 
decrease systematically with an increasing number of 
diagnoses in both men and women. However, for phys- 
ical well-being this correlation was found only in women. 
In the logistic regression, the same social and psychi- 
atric factors predicted women's psychological nd phys- 
ical well-being and the predictive power of those factors 
was much higher in women than in men. In fact, men's 
physical well-being did not correlate at all with any of the 
measures, and their psychological well-being correlated 
only with two variables (simple phobia and income). 
These findings can be interpreted as an expression of 
women's more holistic experience of well-being, whereas 
men experience physical well-being as independent from 
psychiatric disorders and social factors. 
The obvious limitations of this study are the relatively 
small sample size and the selection of a cohort at the age 
of 35. A further limitation is the relatively short instru- 
ment, which measures quality of life in 10 domains. 
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